Original Article J Gynecol Oncol Vol. 26, No. 4:293-302 http://dx.doi.org/10.3802/jgo.2015.26.4.293 pISSN 2005-0380 · eISSN 2005-0399
Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand Siriwan Tangjitgamol, Jakkapan Khunnarong, Sunamchok Srijaipracharoen
Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
Objective: To evaluate the prevalence and features of non-endometrial cancers in Thai endometrial cancer (EC) patients. Methods: EC patients treated in our institution were identified and the following data were collected: age, EC stage, histopathology, adjuvant therapy, other cancers, living status, and cause of death. Results: The mean age of the 344 patients was 56.8±10.8 years. Fifty (14.5%) had other synchronous and metachronous cancers. Mean ages of the patients with or without other cancers were not significantly different, 55.7±10.04 years versus 57.1 ±11.0 years, respectively (p=0.358). History of any cancer in the family and tumor in the lower uterine segment were more frequent among the patients with other cancers (6.0% vs. 1.7%, p=0.095; 12.0% vs. 1.0%, p
Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand Siriwan Tangjitgamol, Jakkapan Khunnarong, Sunamchok Srijaipracharoen
Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
Objective: To evaluate the prevalence and features of non-endometrial cancers in Thai endometrial cancer (EC) patients. Methods: EC patients treated in our institution were identified and the following data were collected: age, EC stage, histopathology, adjuvant therapy, other cancers, living status, and cause of death. Results: The mean age of the 344 patients was 56.8±10.8 years. Fifty (14.5%) had other synchronous and metachronous cancers. Mean ages of the patients with or without other cancers were not significantly different, 55.7±10.04 years versus 57.1 ±11.0 years, respectively (p=0.358). History of any cancer in the family and tumor in the lower uterine segment were more frequent among the patients with other cancers (6.0% vs. 1.7%, p=0.095; 12.0% vs. 1.0%, p
